Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Cytori Therapeutics
3175
Cytori Therapeutics
Health Care
Medical
Technology
Biotechnology
Developing cell therapies for significant medical conditions including hand scleroderma, knee osteoarthritis, thermal burns and stress urinary incontinence.
Suggest edits
Founded
1996
Raised
$67.6M
Follow us
Also headquartered in San Diego
Qualcomm
Intuit
Dan
Edge
GoFundMe
Industry
Illumina
TuSimple
Bandsintown
San Diego Comic-Con
Companies in the same industry
Napo Pharmaceuticals
Auspherix
Amblyotech
Greenmark Biomedical
EndoSpan
Singulex
Ritter Pharmaceuticals, Inc.
Quartet Medicine
Codiak Biosciences
miPS Labs
Alexa global traffic share
Twitter followers
Overview
Funding
4
Acquisitions
1
Add info
Add round
16 Jun
2016
$17,100,000
Post-IPO equity
Cytori Closes Rights Offering for Gross Proceeds of $17.1 Million | Business Wire
businesswire
+1
08 Oct
2014
$13,500,000
Post-IPO equity
30 May
2014
$10,000,000
Post-IPO equity
01 Jul
2013
$27,000,000
Debt financing
Silicon Valley Bank
,
GE Capital
,
Oxford Finance
